LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
467
Total Value
$91,490.04
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 2, 2026 | Sale | 39 | $191.00 | $7,449.00 | 43,615 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 1 | $192.18 | $192.18 | 43,614 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 23 | $195.60 | $4,498.91 | 43,591 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 381 | $196.36 | $74,814.46 | 43,210 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 23 | $197.19 | $4,535.48 | 43,187 | Direct | โ | View Details |